Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Corium International, Inc.

TRADE

NASDAQ: CORIHealthcare / Biotechnology / USA
12.5700.00Vol 887 1471Y Perf 23.96%
Oct 17th, 2018 16:00
BID12.56 ASK12.57
Open12.57 Previous Close12.57
Pre-Market- After-Trading12.57
 - -%  - -%
Target Price
13.25 
Analyst Rating
Strong Buy 1.25
Potencial %
5.41 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/-68 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-11 
Growth Ranking
     21.09
Insiders Shares Cnt. % 3/6/12M
-100/-100/-19 
Income Ranking
 —    -
Market Cap (mil)456 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
79.88 
Earnings Date
15th Nov 2018

Today's Price Range

12.5612.60

 

52wk Range

7.1713.93

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
40.76%
3 Months
57.52%
6 Months
16.71%
1 Year
23.96%
3 Years
47.19%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CORI12.570.00000.00
AAPL221.19-0.9600-0.43
GOOG1 115.69-5.5900-0.50
MSFT110.71-0.2900-0.26
XOM81.500.30000.37
WFC54.460.73001.36
JNJ139.462.90002.12
FB159.420.64000.40
GE12.190.09000.74
JPM109.831.21001.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 7.40
Current Ratio 7.60
Long Term Debt to Total Capital 0.74
Total Debt to Equity 2.83
Interest Coverage -4.60
Leverage Ratio 4.70
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin25.60
EBIT Margin-127.70
EBITDA Margin-123.00
Pre-tax Profit Margin-100.80
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 18.63
PS Ratios 17.62
Price to Cash Flow -
Price to Free Cash Flow -12.50
Cash Flow Per Share -1.18
Price to Tangible Book18.63
Book Value per Share0.68
Enterprise Value (in ths.)451 660
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)147.75
ROE last 12 Months -213.58
Return on Assets (5Y Avg) -26.05
ROA last 12 Months -53.98
Return on Capital (5Y Avg) -42.16
ROC last 12 Months -54.14
Return on invested Capital Q -9.34
Return on invested Capital Y-64.99
Assets Turnover0.30
Receivables Turnover6.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)26 325
Revenue per Share 0.72
Revenue Growth 3 Years -11.66
Revenue Growth 5 Years -11.07
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.39-0.3412.82
Q02 2018-0.41-0.50-21.95
Q01 2018-0.43-0.3713.95
Q04 2017-0.43-0.3616.28
Q03 2017-0.30-0.43-43.33
Q02 2017-0.41-0.42-2.44
Q01 2017-0.43-0.46-6.98
Q04 2016-0.39-0.42-7.69
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.3310.81Positive
9/2018 QR-0.372.63Positive
9/2018 FY-1.533.77Positive
9/2019 FY-1.422.74Positive
Next Report Date15th Nov 2018
Estimated EPS Next Report-0.33
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume887 147
Shares Outstanding (in ths.)36 250
Trades Count2 311
Dollar Volume10 932 356
Avg. Volume425 731
Avg. Weekly Volume7 213 237
Avg. Monthly Volume1 975 269
Avg. Quarterly Volume754 887

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

56%44%

Bearish Bullish

56%44%

Bearish Bullish

60%40%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.25
Strong Buy
1.25
Strong Buy
1.25

There are no comments yet.

News

x